Uzbek Gold Miner Said to Eye $20 Billion Value in Dual Listing
Navoi Mining & Metallurgical Co., one of the world's largest gold producers, has picked banks to lead a potential initial public offering in London and Tashkent, Uzbekistan, hoping to capitalize on a recent rally in the price of the precious metal, according to people familiar with the matter.
The Uzbekistan state-backed miner is seeking a valuation of around $20 billion including debt, two of the people said, citing a nearly 30% surge in the price of gold this year and trading multiples of other gold miners. Gold miners including Newmont Corp. and Barrick Mining Corp. have seen their share prices soar this year amid the run-up in gold prices.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Will Starlink SPAC or IPO in 2025?
Key Points There are few private companies worth more than SpaceX, and many investors would like to own a piece of it. CEO Elon Musk has shown little interest in taking the rocket part of SpaceX public. However, Musk has been receptive to the idea of a spinoff and subsequent IPO of the Starlink satellite internet business. These 10 stocks could mint the next wave of millionaires › For years, many investors have been waiting to get a piece of SpaceX, the massive space exploration company led by Tesla (NASDAQ: TSLA) CEO Elon Musk. According to most lists, SpaceX is the most valuable private company in the world. Unfortunately, Musk has given no indication that he is even remotely interested in taking SpaceX public. However, there's another possibility that could be interesting. SpaceX is the parent company of the Starlink satellite internet service, and there is a strong possibility that Starlink could be spun off at some point and go public, either by the traditional IPO process or via special purpose acquisition company, or SPAC. What we know, and what we don't One thing we know with near certainty is that SpaceX is unlikely to go public in its entirety -- at least not anytime soon. But SpaceX could spin off Starlink and take it public as a standalone business, and most reports and comments from insiders have indicated that it's the most likely route the company could take. We also know that CEO Elon Musk has addressed this issue several times. In fact, one of the reasons that many investors think a Starlink IPO could be coming soon is that in 2022, Musk told SpaceX employees that a Starlink IPO wasn't likely until 2025 or later. He said that the business needed to achieve predictability and to be "in a smooth sailing situation" before an IPO, and with most reports indicating that Starlink is nicely profitable and generating billions in recurring revenue, there's an argument to be made that Musk's benchmarks have been met. On the other hand, in a 2023 post on X, Musk told investors that Starlink wasn't having any problems raising money through private investors, and therefore it didn't make sense to go through the trouble of taking Starlink public. More recently, Musk said at a 2025 conference that it's "possible that Starlink may go public at some point in the future," but he didn't seem to be in any rush to make it happen. How much could Starlink be worth as a public company? SpaceX, the parent of Starlink, is reportedly valued at about $400 billion in the private markets, based on a $1 billion share sale in July. When it comes to the standalone value of Starlink, which makes up the bulk of SpaceX's revenue according to most estimates, it's a little more difficult. Plus, the potential valuation depends on whom you ask. One analyst estimates that Starlink will reach $12.3 billion in revenue in 2025. As far as how this might translate into a market value, estimates have varied widely. Most estimates have been in the $30 billion to $100 billion range, although billionaire investor Ron Baron said that Starlink will go public at a valuation in the $250 billion to $300 billion range, but that it won't happen until about 2027. The bottom line While a Starlink (or SpaceX) IPO isn't out of the question, I don't view it as likely to happen in 2025. For one thing, Starlink has become a cash machine for SpaceX and is instrumental in funding its development. And as we've seen with virtually every private funding round and stock sale, SpaceX has absolutely no difficulty in raising money through private investors. As mentioned, Musk indicated this in a 2023 post, and I'd argue that it's even easier for Starlink to raise money now. If Starlink does go public, I'd say there's a higher probability of a traditional IPO than a SPAC. It would likely be the largest SPAC target of all time if it chooses that route, and while both processes have their pros and cons, the poor record of SPAC IPO performance might scare Musk away from this route. To sum it up, I'm not holding my breath for a Starlink IPO in 2025, even though Musk has said that he'd eventually like to do one. It may come later, but I just don't see Musk in any particular rush to take the company public. Don't miss this second chance at a potentially lucrative opportunity Ever feel like you missed the boat in buying the most successful stocks? Then you'll want to hear this. On rare occasions, our expert team of analysts issues a 'Double Down' stock recommendation for companies that they think are about to pop. If you're worried you've already missed your chance to invest, now is the best time to buy before it's too late. And the numbers speak for themselves: Nvidia: if you invested $1,000 when we doubled down in 2009, you'd have $473,820!* Apple: if you invested $1,000 when we doubled down in 2008, you'd have $43,540!* Netflix: if you invested $1,000 when we doubled down in 2004, you'd have $653,427!* Right now, we're issuing 'Double Down' alerts for three incredible companies, available when you join , and there may not be another chance like this anytime soon.*Stock Advisor returns as of August 11, 2025 Matt Frankel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Tesla. The Motley Fool has a disclosure policy. Will Starlink SPAC or IPO in 2025? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 minutes ago
- Yahoo
HeartFlow IPO success reflects market embrace of AI in medtech industry
HeartFlow's $364m initial public offering (IPO) signals market validation for the use of artificial intelligence (AI) in a company's product portfolio, an expert says. Roundly exceeding its $300m expectations for the IPO, the Bain Capital-backed AI-based coronary artery disease (CAD) platform developer debuted with a a $2.2bn valuation on the Nasdaq on 8 August. HeartFlow's current products are HeartFlow Plaque analysis, which aims to provide clinicians with the ability to more accurately assess patients with arterial plaque buildup (atherosclerosis), and HeartFlow FFRCT analyses CT angiogram (CCTA). Typically used alongside Plaque Analysis, FFRCT creates detailed 3D models of the arteries to assess the impact of blockages on blood flow. Plaque Analysis received US Food and Drug Administration (FDA) clearance in 2022 and is claimed to be the only AI-based plaque quantification tool currently cleared by the agency. FFRCT received FDA clearance in 2014. To reach the IPO milestone, HeartFlow maintained a focus on testing its product offerings alongside physicians, generating real world evidence, taking on feedback and refining as needed, and ensuring they were truly ready to scale. HeartFlow also navigated the structural barriers of getting its product to market; again, real-world evidence – with over 3,000 peer-reviewed papers demonstrating its products' efficacy – spurred the company's commercialisation efforts. Medtech industry veteran, Brent Ness, CEO of Aclarion, who served as HeartFlow's chief commercial officer from 2014 to 2015, told Medical Device Network that HeartFlow's work on the underlying economic factors around its product, including working on contractual relationships with imaging centres to get them on board with the product, pre-reimbursement, have proven a key part of its success. 'Between FDA clearance and reimbursement, lots of technologies can't make it through that journey because there's no reimbursement, and therefore there's no adoption, and they run out of cash,' Ness explained. 'Part of the structural barrier stage of development involves getting the provider economics right and that market access work that needs to take place between the early payors and the key opinion leaders (KOL) advocating for the product. But payors aren't going to turn it on just because a KOL says so. 'This is why the shining jewel in HeartFlow's history has been their absolute commitment to leading with evidence.' AI's recognition in healthcare and its future According to Ness, the success of HeartFlow's IPO reflects the market validation of the overall rationale for using AI in imaging and the deployment of software-as-a-service (SaaS) based products as the 'raw material' underpinning the technology's ability to provide clinically actionable information and improve patient outcomes. Ness said this model is 'here to stay', having been 'completely validated by the market, which has recognised of its value, which obviously translates into revenue, and speaks to the long term success and viability of HeartFlow and the significant potential for other AI-based SaaS imaging developers.' To learn from HeartFlow's success, Ness views a critical role for SaaS-based AI software providers as being to try and shorten the timeframe between regulatory approval and reimbursement. 'The faster that new and novel technologies using AI can move through that Death Valley, the better it's going to be for patients, and the more money we're going to save as a collective society,' Ness said. 'The 'muscle' of these AI tools is proving to be valuable. It's got to be safe, and it's got to make sense economically, but we've got to figure out how to shorten that part of the journey.' "HeartFlow IPO success reflects market embrace of AI in medtech industry" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 minutes ago
- Yahoo
Gold Mine Visible From Space Set For An IPO
Navoi Mining & Metallurgical Company (NMMC), Uzbekistan's state-owned mining giant, is preparing for an initial public offering that would make it the world's fourth-largest publicly listed gold miner. Uzbekistan, a landlocked Central Asian nation bordering Kazakhstan, Turkmenistan, and Afghanistan, has been rapidly modernizing its mining sector under President Shavkat Mirziyoyev's economic reforms. NMMC has taken a central role in that effort, as the miner contributes 6.5% of GDP and ranks among the largest employers in the country. "It's a very exciting time now from an investment point of view. Uzbekistan is an alpha mining market," Eugene Antonov, the firm's deputy general director, recently said for intellinews."There is still so much to be found; only a third of the country has been geologically surveyed and the Kyzyl-Kum desert barely at all," he added. While gold is NMMC's flagship commodity, Uzbekistan's mineral wealth also includes uranium, copper, silver, molybdenum, zinc, tungsten, and rare earth elements. The country is among the world's top uranium producers, with operations managed separately under Navoiuran. NMMC's principal asset is Muruntau – the largest open-pit gold mine in the world. This asset, visible from space, has reserves estimated at 150 million ounces. The quarry spans 3.3 km in length, 2.5 km in width, and more than 600 meters deep. Muruntau produces around 60 tons of gold annually, representing 70% of NMMC's total resources. In 2023, the company mined 2.9 million ounces of gold at one of the lowest production costs globally, $979 per ounce, generating $7.4 billion in revenue and $4.5 billion in EBITDA. Pursuing the broader privatization agenda, the government plans to sell up to 5% of NMMC. Bloomberg reported that the deal would involve a dual listing on the London Stock Exchange and the Tashkent Republican Stock Exchange, citing anonymous sources. Yet before that, NMMC reorganized into a joint-stock company, appointed independent directors, and adopted international reporting standards. The company has already tested investor appetite through two oversubscribed Eurobond issuances totaling $1.5 billion. The management is also proud of the environmental, social, and governance plan, which targets 21% of energy from renewables by 2026. "We don't just have an obligation to shareholders," Antonov said. "We aim to be a sustainable producer for the benefit of the people of Uzbekistan." Per Bloomberg, financial multinational heavyweights like Citigroup, Morgan Stanley, and JPMorgan are involved in the IPO, while Rothschild & Co. is an advisor. The listing would potentially value NMMC at $20 billion, including debt. Still, insiders warn that no final decisions have been made, and the situation regarding the scope and the location of the listing might change. Read Next:Image via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article Gold Mine Visible From Space Set For An IPO originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
